Interesting article by Kathy Liszewski over at Genetic Engineering and Biotechnology News looking at circulating tumor cells (CTCs) incorporated with digital pathology. There is little doubt in my mind that technologies involving CTCs,...

SAN DIEGO, March 2, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating tumor cells (CTCs), today announced that...